IL189545A0 - Pyrimidine derivatives and their use as kcnq potassium channels openers - Google Patents
Pyrimidine derivatives and their use as kcnq potassium channels openersInfo
- Publication number
- IL189545A0 IL189545A0 IL189545A IL18954508A IL189545A0 IL 189545 A0 IL189545 A0 IL 189545A0 IL 189545 A IL189545 A IL 189545A IL 18954508 A IL18954508 A IL 18954508A IL 189545 A0 IL189545 A0 IL 189545A0
- Authority
- IL
- Israel
- Prior art keywords
- pyrimidine derivatives
- potassium channels
- kcnq potassium
- channels openers
- openers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/50—Three nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200501262 | 2005-09-09 | ||
| PCT/DK2006/050039 WO2007065449A1 (en) | 2005-09-09 | 2006-09-07 | Pyrimidine derivatives and their use as kcnq potassium channels openers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL189545A0 true IL189545A0 (en) | 2008-06-05 |
Family
ID=37199174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL189545A IL189545A0 (en) | 2005-09-09 | 2008-02-14 | Pyrimidine derivatives and their use as kcnq potassium channels openers |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1937653A1 (en) |
| JP (1) | JP2009507052A (en) |
| KR (1) | KR20080043314A (en) |
| CN (1) | CN101258133A (en) |
| AR (1) | AR055420A1 (en) |
| AU (1) | AU2006322461A1 (en) |
| BR (1) | BRPI0615631A2 (en) |
| CA (1) | CA2621854A1 (en) |
| EA (1) | EA200800780A1 (en) |
| IL (1) | IL189545A0 (en) |
| MX (1) | MX2008002294A (en) |
| NO (1) | NO20081713L (en) |
| UA (1) | UA93387C2 (en) |
| WO (1) | WO2007065449A1 (en) |
| ZA (1) | ZA200802174B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100256145A1 (en) * | 2007-08-01 | 2010-10-07 | H. Lundbeck A/S | Use of kcnq potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted |
| US7786146B2 (en) * | 2007-08-13 | 2010-08-31 | Valeant Pharmaceuticals International | Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
| WO2010097379A1 (en) * | 2009-02-24 | 2010-09-02 | Neurosearch A/S | Substituted pyrimidin derivatives and their medical use |
| AU2011275393B2 (en) * | 2010-07-08 | 2014-04-10 | Pfizer Inc. | Piperidinyl pyrimidine amides as Kv7 potassium channel openers |
| CA2815131C (en) * | 2010-10-20 | 2020-06-09 | Gruenenthal Gmbh | Substituted 6-amino-nicotinamides as kcnq2/3 modulators |
| CN103508960B (en) * | 2012-06-29 | 2017-12-12 | 江苏先声药业有限公司 | Benzheterocyclic derivatives |
| CN103508943B (en) * | 2012-06-29 | 2017-06-09 | 江苏先声药业有限公司 | As the compound of potassium channel modulating agents |
| MX2017005044A (en) | 2014-10-24 | 2017-07-04 | Ono Pharmaceutical Co | Kcnq2-5 channel activator. |
| JP2022543230A (en) * | 2019-08-02 | 2022-10-11 | ハー・ルンドベック・アクチエゼルスカベット | Alcohol derivatives as Kv7 potassium channel openers for use in epilepsy or epileptic seizures |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005508833A (en) * | 2001-02-20 | 2005-04-07 | ブリストル−マイヤーズ スクイブ カンパニー | 2,4-disubstituted pyrimidine-5-carboxamide derivatives as KCNQ potassium channel modulators |
| AU2003202115A1 (en) * | 2002-02-12 | 2003-09-04 | Pfizer Inc. | Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh) |
| US20080261918A1 (en) * | 2004-12-17 | 2008-10-23 | Graham Andrew Showell | Silicon Compounds and Their Use |
-
2006
- 2006-09-07 KR KR1020087004306A patent/KR20080043314A/en not_active Application Discontinuation
- 2006-09-07 CA CA002621854A patent/CA2621854A1/en not_active Abandoned
- 2006-09-07 ZA ZA200802174A patent/ZA200802174B/en unknown
- 2006-09-07 WO PCT/DK2006/050039 patent/WO2007065449A1/en active Application Filing
- 2006-09-07 EA EA200800780A patent/EA200800780A1/en unknown
- 2006-09-07 BR BRPI0615631-2A patent/BRPI0615631A2/en not_active IP Right Cessation
- 2006-09-07 CN CNA2006800327125A patent/CN101258133A/en active Pending
- 2006-09-07 JP JP2008529473A patent/JP2009507052A/en not_active Withdrawn
- 2006-09-07 EP EP06846967A patent/EP1937653A1/en not_active Withdrawn
- 2006-09-07 UA UAA200803570A patent/UA93387C2/en unknown
- 2006-09-07 MX MX2008002294A patent/MX2008002294A/en active IP Right Grant
- 2006-09-07 AU AU2006322461A patent/AU2006322461A1/en not_active Abandoned
- 2006-09-08 AR ARP060103924A patent/AR055420A1/en not_active Application Discontinuation
-
2008
- 2008-02-14 IL IL189545A patent/IL189545A0/en unknown
- 2008-04-09 NO NO20081713A patent/NO20081713L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007065449A1 (en) | 2007-06-14 |
| KR20080043314A (en) | 2008-05-16 |
| AU2006322461A1 (en) | 2007-06-14 |
| NO20081713L (en) | 2008-06-04 |
| CN101258133A (en) | 2008-09-03 |
| UA93387C2 (en) | 2011-02-10 |
| ZA200802174B (en) | 2009-10-28 |
| EP1937653A1 (en) | 2008-07-02 |
| AR055420A1 (en) | 2007-08-22 |
| MX2008002294A (en) | 2008-03-14 |
| EA200800780A1 (en) | 2008-06-30 |
| BRPI0615631A2 (en) | 2011-05-24 |
| JP2009507052A (en) | 2009-02-19 |
| CA2621854A1 (en) | 2007-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL186939A0 (en) | Pyrimidine derivatives and their use as | |
| ZA200805294B (en) | Pyrimidine derivatives | |
| IL189545A0 (en) | Pyrimidine derivatives and their use as kcnq potassium channels openers | |
| IL181433A0 (en) | Pyrimidine derivatives | |
| GB0525080D0 (en) | Pyrimidine derivatives | |
| GB0525083D0 (en) | Pyrimidine derivatives | |
| IL181386A0 (en) | Pyrimidine derivatives | |
| EP2223921B8 (en) | 2-Thiophen-2-yl-oxazole, 2-Thiophen-2-yl-thiazole and 2-Thiophen-2-yl-1H-imidazole derivatives as antiviral agents | |
| GB0415364D0 (en) | Pyrimidine derivatives | |
| HK1104553A1 (en) | Pyrimidine derivatives | |
| EP1724267A4 (en) | Pyrimidine derivative | |
| HRP20130719T1 (en) | Novel pyridine derivative and pyrimidine derivative (3) | |
| IL185914A0 (en) | Pyrimidine compounds and methods of use | |
| ZA200806153B (en) | Pyrimidine derivatives | |
| EP1951680A4 (en) | Novel 2-aminopyrimidinone derivatives and their use | |
| GB0525081D0 (en) | Pyrimidine derivatives | |
| GB0614579D0 (en) | Pyrimidine derivatives | |
| EP1847541A4 (en) | Fused pyrimidine derivative and uses thereof | |
| HK1126204A1 (en) | Substituted bicyclic pyrimidone derivatives | |
| EP1951681A4 (en) | Novel 2-aminopyrimidine derivatives and their use | |
| ZA200810565B (en) | Pyrimidine derivatives and their use as pesticides | |
| GB0415367D0 (en) | Pyrimidine derivatives | |
| HK1143152A1 (en) | 2-thiophen-2-yl-oxazole, 2-thiophen-2-yl-thiazole and 2-thiophen-2-yl-1h- imidazole derivatives as antiviral agents | |
| AU2005900326A0 (en) | Roller reamer | |
| ZA200804208B (en) | Oxygen linked pyrimidine derivatives |